Trade

IOL Chemicals & Pharmaceuticals Ltd share price

Balanced risk
  • 45%Low risk
  • 45%Moderate risk
  • 45%Balanced risk
  • 45%High risk
  • 45%Extreme risk
  • 73.92(-0.74%)
    January 19, 2026 15:29:03 PM IST
    • NSE
    • BSE
  • Vol : 672.56 K (NSE + BSE)
    Last 20 day avg : 579.32 K

IOL Chemicals & Pharmaceuticals Ltd is trading -0.74% lower at Rs 73.92 as compared to its last closing price. IOL Chemicals & Pharmaceuticals Ltd has been trading in the price range of 75.68 & 73.78. There are 2 analysts who have initiated coverage on IOL Chemicals & Pharmaceuticals Ltd. There are 2 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 29.97 Crores in its last quarter.Listed peers of IOL Chemicals & Pharmaceuticals Ltd include Solar Industries India (0.53%), Asian Paints (-0.24%), SRF (-2.45%).The Mutual Fund holding in IOL Chemicals & Pharmaceuticals Ltd was at 0.02% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in IOL Chemicals & Pharmaceuticals Ltd was at 2.25% in 30 Sep 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jan 19, 2026, 12:38 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.99
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.07
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.96
    Inline with the industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    1.44
    In line with historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    21.01
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
73.78
Highest
75.68
52 week range
Lowest
57.51
Highest
126.60
IOL Chemicals & Pharmaceuticals Ltd Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Solar Industries India
Bearish
12,902.400.531,16,753.8990.2625.760.089.52
Asian Paints
Neutral
2,750.20-0.242,64,268.2868.0113.770.907.13
SRF
Bearish
2,951.70-2.4587,358.5873.187.270.2516.14
Pidilite Industries
Bearish
1,469.65-0.441,49,416.5270.1715.090.692.26
Coromandel International
Bearish
2,265.00-2.4666,836.6039.156.370.505.40
Mutual Fund Ownership
View all
Bandhan BSE Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.02
  • % of AUM 0.08
IOL Chemicals & Pharmaceuticals Ltd Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-11Quarterly Results
2025-08-07Quarterly Results
2025-05-16Audited Results
2025-02-12Quarterly Results & Interim Dividend
2024-12-27Stock Split
About the company IOL Chemicals & Pharmaceuticals Ltd
  • IndustryChemical Manufacturing
  • ISININE485C01029
  • BSE Code524164
  • NSE Code
IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.
  • Management Info
  • Pardeep KhannaChief Financial Officer
  • Abhay SinghVice President, Company Secretary
  • Varinder GuptaManaging Director, Executive Director
  • Vikas GuptaJoint Managing Director, Executive Director
  • Abhiraj GuptaExecutive Director
  • Kushal RanaExecutive Director, Director - Works
IOL Chemicals & Pharmaceuticals Ltd Share Price FAQs

IOL Chemicals & Pharmaceuticals Ltd is trading at 73.92 as on Mon Jan 19 2026 09:59:03. This is -0.74% lower as compared to its previous closing price of 74.47.

The market capitalization of IOL Chemicals & Pharmaceuticals Ltd is 2169.76 Cr as on Mon Jan 19 2026 09:59:03.

The average broker rating on IOL Chemicals & Pharmaceuticals Ltd is Strong Buy. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 0.00 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for IOL Chemicals & Pharmaceuticals Ltd is 126.60 whereas the 52 wk low is 57.51

IOL Chemicals & Pharmaceuticals Ltd can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: -
  • Dividend Yield: %
  • D/E ratio: -

IOL Chemicals & Pharmaceuticals Ltd reported a net profit of 101.07 Cr in 2025.

The Mutual Fund Shareholding was 0.02% at the end of 30 Sep 2025.